RECRUITING

Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

Description

Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.

Conditions

Electronic Nicotine Delivery SystemsTobacco ProductsCigarette Smoking
Talk to us

Related Conditions:

Electronic Nicotine Delivery SystemsTobacco ProductsCigarette Smoking

Study Overview

On this page

Study Details

Study overview

Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.

Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

Condition
Electronic Nicotine Delivery Systems
Intervention / Treatment

-

Contacts and Locations

Chicago

University of Chicago BREATHE Laboratory, Chicago, Illinois, United States, 60637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 18-26 years old, ability to understand the English language, willing and able to provide informed consent
  • 2. Current ENDS user (at least 4 out of 7 days per week of use for the past one month); for focus groups, at least half of participants will report current cigarette smoking (at least 1 cigarette per day on at least 1 day per week in the past month)
  • 3. Report interest in quitting or reducing ENDS (at least 6/10 scale in interest of quitting or reducing
  • 4. Does not currently (in past one year) meet criteria for major psychiatric disorder including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
  • 5. For women, not currently pregnant, planning to become pregnant, or breastfeeding due to lack of information on ENDS use and possible harms from NRT during pregnancy
  • 6. Not currently using smoking cessation medication (i.e., Varenicline, Bupropion
  • 7. No history of adverse reactions to nicotine replacement therapy
  • 1. Does not own a mobile phone or is unwilling to receive text messages to their device
  • 2. No interest in quitting or reducing use of ENDS
  • 3. Uses electronic cigarettes less than 4 days per week in the past month
  • 4. Reports past-year serious psychiatric illness, including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
  • 5. Is currently using smoking cessation medication including Varenicline or Bupropion
  • 6. Are a female who is currently pregnant or nursing or planning to become pregnant within the next 6 months

Ages Eligible for Study

18 Years to 26 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Chicago,

Study Record Dates

2026-02